Greg Baker, PhD
Director of Business Development
Greg is the Director of Business Development for the Technology & Innovation Development Office (TIDO) at Boston Children’s Hospital.
Greg’s role at TIDO is to help commercialize technologies developed at Boston Children’s Hospital. Greg works with the licensing team and the faculty at all stages of the innovation life cycle, from conception to the transition to the marketplace. He draws upon his experience in technology commercialization at academic institutions such as Children’s National in Washington D.C. and Children’s Hospital of Philadelphia, as well as business development roles at Novartis and Syngenta. His experience also includes supporting startup companies during their initial formation and with competing for early-stage funding, and he is also a registered patent agent.
Greg’s business experience supplements his scientific training of an undergraduate degree in Microbiology from the University of California, San Diego, and a PhD in Molecular Genetics from Harvard Medical School.
Greg joined BCH in February 2021, and he is excited to be part of the TIDO team.